| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | p54 | Structure of the N-domain of GRP94 bound to the HSP90 inhibitor PU-H54 | 3o2f | 94.4 |
| 2 | 9qy | Structure of GRP94 N-terminal Domain bound to resorcinylic inhibitor BnIm. | 5wmt | 92.77 |
| 3 | nei | N-Domain Of Grp94 In Complex With the 2-Iodo-NECA | 2h8m | 91.2 |
| 4 | eqd | Structure of GRP94 with a resorcinylic inhibitor. | 6c91 | 90.32 |
| 5 | d57 | Structure of GRP94 with a selective resorcinylic inhibitor. | 6baw | 90.05 |
| 6 | rdc | N-Domain Of Grp94 Lacking The Charged Domain In Complex With Radicicol | 1u0z | 88.88 |
| 7 | 6c0 | Crystal structure of Grp94 bound to methyl 3-chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, an inhibitor based on the BnIm and Radamide scaffolds. | 5in9 | 88.8 |
| 8 | cdy | Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with 2-chlorodideoxyadenosine | 1qye | 88.52 |
| 9 | vc4 | Structure of Grp94 bound to methyl 2-[2-(2-benzylpyridin-3-yl)ethyl]-3-chloro-4,6-dihydroxybenzoate, a pan-Hsp90 inhibitor | 6asq | 86.68 |
| 10 | rde | GRP94 in complex with the novel HSP90 Inhibitor Radester amine | 2fyp | 86.4 |
| 11 | v2c | Structure of Grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 H-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate, a Grp94-selective inhibitor and promising therapeutic lead for treating myocilin-associated glaucoma | 6asp | 86.24 |
| 12 | vc5 | Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 2-[2-(2-benzylphenyl)ethyl]-3-chloro-4,6-dihydroxybenzoate | 6aom | 85.7 |
| 13 | 2lc | Correlation between chemotype-dependent binding conformations of HSP90 alpha/beta and isoform selectivity | 4nh9 | 84.92 |
| 14 | rda | GRP94 in complex with the novel HSP90 Inhibitor Radamide | 2gfd | 84.22 |
| 15 | pa7 | N-Domain Of Grp94 In Complex With the Novel Ligand N-Propyl Carboxyamido Adenosine | 2gqp | 84.11 |
| 16 | vc1 | Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 3-chloro-2-(2-{2-[(4-fluorophenyl)methyl]phenyl}ethyl)-4,6-dihydroxybenzoate | 6aol | 82.96 |
| 17 | nec | Crystal Structure Of The N-Domain Of Grp94 Lacking The Charged Domain In Complex With Neca | 1u2o | 81.28 |
| 18 | nec | Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Conformational Change, GRP94N(DELTA)41 APO CRYSTAL SOAKED WITH NECA | 1ysz | 81.22 |
| 19 | gdm | GRP94 N-terminal Domain bound to geldanamycin | 2exl | 79.99 |
| 20 | nec | Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with the specific ligand NECA | 6d28 | 79.92 |
| 21 | pa7 | N-Domain Of Grp94, with the Charged Domain, In Complex With the Novel Ligand N-Propyl Carboxyamido Adenosine | 6d1x | 79.45 |
| 22 | gdm | GRP94 n-terminal domain bound to geldanamycin: effects of mutants 168-169 KS-AA | 2esa | 77.98 |
| 23 | 7ky | Crystal structure of Grp94 bound to isoform-selective inhibitor methyl 2-(2-(1-(4-bromobenzyl)-1H-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate | 5ttz | 74.1 |